Table 2.
Markers (number of positive studies/total studies reported) | Capsaicin/capsaicinoids dose∗ | Potential biological effects |
---|---|---|
Energy expenditure (N = 18/20 studies) | 3–30 mg/d | Increase in EE for 30 min [12, 22–25, 27, 36, 51, 64], [15]∗ |
| ||
Lipid oxidation and fat loss (15/18 studies) | 1–30 mg/d | Increase in lipid oxidation and decreased abdominal/body fat [13, 18, 22–24, 27], [15]∗ |
| ||
Lipolysis (1/1) | 2 mg | Tolerable dose, increased plasma FFA (2 hr and 2.5 hr), and glycerol (4 hr) concentrations [16] |
| ||
Appetite (7/9 studies) | 2–30 mg | Decrease in appetite, decrease in energy intake, and increase in satiety [13, 20–23, 28, 36, 49] |
| ||
Weight management markers (3/3) | 2 mg | Body indices (waist circumference, hip circumference, and WHR); appetite; lipolysis [16, 28, 49] |
∗Cross reference.